In addition to anti-PD-1/PD-L1 or anti-CTLA-4 treatment strategies, tumour-associated macrophages (TAMs) [10] and cancer-associated fibroblasts (CAFs) [11] have also been previously reported as potential strategies for cancer treatment research. The gene discussed is CTLA4; the disease is cancer.